Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 447

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 447
---
 also agreed that from the date of the March Purchase Agreement until one year after the closing date of the offering, we shall not enter into an agreement to effect any issuance by us or any of our subsidiaries of NLS Common Shares or NLS Common Share equivalents (or a combination of units thereof) involving a variable rate transaction. The offering resulted in gross proceeds to us of $1,750,000. NLS intends to use the net proceeds from the offering for working capital and general corporate purposes. On June 28, 2024, we entered into a securities purchase agreement providing for the issuance in a registered direct offering of 81,944 NLS Common Shares at a purchase price of $9.60 per share. In addition, the investors in the offering received unregistered warrants to purchase up to an aggregate of 81,944 NLS Common Shares at an exercise of $9.60 per share in a concurrent private placement. The common warrants were immediately exercisable upon issuance and expire five years following the date of issuance. The agreement includes customary representations, warranties, and indemnification provisions. We agreed not to issue or announce the issuance of any NLS Common Shares or equivalents for 15 days post -closing, with certain exceptions, and not to engage in variable rate transactions for one -yearpost -closing. The offering generated gross proceeds of approximately $786,660. 235 On September 16, 2024, we entered into a warrant amendment agreement with an institutional investor to amend warrants to purchase up to 172,836 NLS Common Shares, adjusting the definition of a “Fundamental Transaction” and the exercise price to CHF 0.80. In exchange for the September Warrant Amendment, the Company agreed to adjust the exercise price in the Common Warrants to CHF 0.02, and following the Company increasing its authorized NLS Common Shares, issued to the investor, pre -fundedwarrants to purchase up to 191,431shares of NLS Common Shares, or the Pre -FundedWarrants. On October 9, 2024, we entered into a securities purchase agreement with certain accredited investors. Under this agreement, we issued and sold 806,452 NLS Common Shares and warrants to purchase an additional 806,452 NLS Common Shares, at a combined purchase price of $3.97, for aggregate gross proceeds of $3.2 million. The warrants have a term of five years and an exercise price of $4.25 per share. Investors were granted